A Trial Looking at Rituximab and Chemotherapy as a Treatment for Follicular Lymphoma in Elderly Patients
Status:
Unknown status
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether R-FC is more beneficial that R-CVP in the
treatment of older patients (aged 60 or over) with Follicular Lymphoma (FL).
Phase:
Phase 3
Details
Lead Sponsor:
University of Liverpool
Collaborators:
Cancer Research UK Liverpool University Hospitals NHS Foundation Trust Roche Pharma AG Royal Liverpool and Broadgreen University Hospitals NHS Trust